Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HZ 166

Known as: HZ-166, HZ166 cpd 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BACKGROUND Previous studies have investigated α1GABAA and α5GABAA receptor mechanisms in the behavioral effects of ethanol (EtOH… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
2018
2018
&NA; HZ‐166 has previously been characterized as an &agr;2,3‐selective GABAA receptor modulator with anticonvulsant, anxiolytic… Expand
  • table 2
  • table 4
  • table 3
  • figure 3
  • figure 4
2018
2018
In nonhuman primates we tested a new set of behavioral categories for observable sedative effects using pediatric anesthesiology… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2017
2017
RationaleGABAA positive allosteric modulators (GABAA PAMs), such as diazepam and zolpidem, are used clinically for anxiety and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2016
2016
1,4-Benzodiazepines are used in the treatment of anxiety disorders but have limited long-term use due to adverse effects. HZ-166… Expand
2016
2016
INTRODUCTION Automated patch clamp is a recent but widely used technology to assess pre-clinical drug safety. With the… Expand
2013
2013
RationaleAssays of schedule-controlled responding can be used to characterize the pharmacology of benzodiazepines and other GABAA… Expand
  • figure 1
  • figure 2
  • figure 3
2010
2010
Conflict procedures can be used to study the receptor mechanisms underlying the anxiolytic effects of benzodiazepines and other… Expand